Q3 2025 Precipio Inc Earnings Call Transcript
Key Points
- Precipio Inc (PRPO) achieved positive adjusted EBITDA of nearly $0.5 million for the first time in its history.
- The company generated over $0.275 million of cash from operations, marking a significant financial milestone.
- Revenue for Q3 reached $6.8 million, a 30% increase year over year and a 20% increase quarter over quarter.
- The Pathology Services division saw a revenue increase from $5 million in Q2 to $6 million in Q3, driven by new customer acquisitions.
- Gross margins improved from 43% to 44%, with expectations of exceeding 50% by mid-2026 as both divisions scale.
- The Products division experienced a temporary decline in gross margins from 44% to 30% due to strategic investments.
- Incremental annual rent for expanded lab space increased costs by approximately $120,000 per year.
- The addition of a technical support specialist added to operational costs, impacting short-term margins.
- Despite growth, the company still faces challenges in maintaining efficient operations amidst increasing volume.
- The need for strategic investments in infrastructure and personnel may continue to pressure margins in the short term.
Welcome to the Precipio third-quarter 2025 shareholder update conference call.
(Operator Instructions) Please note that the conference is being recorded.
Statements made during this call contain forward-looking statements about our business. You should not place undue reliance on forward-looking statements, as these statements are based upon our current expectations, forecasts, and assumptions; and are subject to significant risks and uncertainties.
These statements may be identified by words such as may, will, should, could, expect, intend, plan, anticipate, believe, estimate, predict, potential, forecast, continue, the negative of these terms, or other words or terms of similar meaning.
Risks and uncertainties that could cause our actual results to differ materially from these set forth in any forward-looking statements include, but are not limited to, the matters listed under Risk Factors in our annual report on Form 10-K for the year ended December 31, 2024, which is on file with the Securities and Exchange Commission; as well as other risks detailed in our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
